Requirements for different pharmaceutical forms or dosages [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2020-07-13 15:52 (872 d 08:35 ago) – Posting: # 21683
Views: 1,032

Dear, what is the guideline from EMA that I would found the bioavailability requirements for different pharmaceutical forms or dosages?
For example, comparing tablet vs suspension (with same dosage), extende release vs immediate release, tablet 500 mg vs tablet 250 mg (with same drug).

Thank you for any help!

Complete thread:

UA Flag
Activity
 Admin contact
22,423 posts in 4,694 threads, 1,600 registered users;
18 visitors (1 registered, 17 guests [including 11 identified bots]).
Forum time: 23:27 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5